OSRHW — OSR Health, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1840425 ·
Last close
$0.01
Market Cap
—
52W High
$0.03
52W Low
$0.01
ADV30
1,512
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 315,669 86,605 -3,032,914 -848,905 166,623,360 1,499,603 41,714,542
Mar 2026 484,057 160,281 -3,667,184 -2,931,461 172,187,773 1,566,701 44,796,654
Dec 2025 381,269 129,704 -6,385,534 -4,822,904 171,238,248 1,700,273 44,200,845
Sep 2025 627,747 261,734 -3,803,465 -2,126,595 177,289,528 2,177,309 43,131,683

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-5,265,922
Investing CF
$-3,816,904
Financing CF
$9,160,892
CapEx
$-173,704
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-40,101,342
Inventory
$462,455
Receivables
$526,259
ST Investments
$0
EBIT TTM
$-20,894,013
Pretax Income TTM
$-21,415,035
Interest Exp TTM
$521,022
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,808,743
EBITDA
$-7,419,085
Free Cash Flow
$-2,679,485
Enterprise Value
—
Total Cash
$1,499,603
Total Debt
$5,462,785
Shares Out
—
Trailing EPS
—
Book Value
$2.97
ROE
-11.3%
ROA
-6.0%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 2,905,805 -18,336,003 -18,010,899 171,238,248 44,200,845 77,635,615 -4,328,034
Dec 2024 3,530,303 -11,692,197 -10,328,910 175,239,579 32,031,363 143,208,216 -1,849,474
Dec 2023 0 -1,830,700 403,780 36,627,733 4,108,272 32,519,461 -818,766
Dec 2022 0 -621,316 1,064,967 120,757,699 21,659,379 99,098,320 -516,309

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $148.61B $414.79 —
MDT Medtronic plc $114.48B $89.50 —
SYK STRYKER CORP $105.60B $275.31 —
MMM 3M CO $87.40B $169.48 —
BSX BOSTON SCIENTIFIC CORP $63.93B $44.11 —

News headlines (Yahoo Finance, 1h cache)

Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.
2026-08-27 21:00 · Yahoo
OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission
2026-08-21 15:45 · Yahoo
Sector Update: Healthcare Stocks Fall Thursday Afternoon
2026-08-20 17:43 · Yahoo
OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal
2026-08-19 19:45 · Yahoo
OSR Health Sees Global Shareholder Momentum at Critical Inflection Point
2026-08-19 10:30 · Yahoo
OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development
2026-08-11 12:52 · Yahoo
OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program
2026-08-07 19:00 · Yahoo
Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform
2026-08-03 13:02 · Yahoo
OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment
2026-07-31 16:00 · Yahoo
OSR Health, A Message From the CEO
2026-07-13 16:37 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.